logo

For the Inventor, By the Inventor

Garwood, NJ, United States of America

Kamil Paruch

This inventor holds 50 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 10 EPO patents, primarily in Protein Kinase Inhibitors (CPC class C07D). Top assignees: Schering Corporation, Pharmacopeia Drug Discovery, Inc., Masarykova Univerzita. Active years: 2005-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kamil Paruch. Retrieved from https://idiyas.com/inventor/kamil-paruch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 50 

% Patents Active = 64.0



Average Co-Inventor Count = 4.8

ph-index = 11

Forward Citations = 316(Granted Patents)

Forward Citations (Not Self Cited) = 309(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Cranford, NJ (US) (2005)
  • Garwood, NJ (US) (2005 - 2014)
  • Tisnov, CZ (2012 - 2023)

Company Filing History:

goldMedal40 out of 1,829 
 
Schering Corporation
 patents
silverMedal6 out of 52 
 
Pharmacopeia Drug Discovery, Inc.
 patents
bronzeMedal5 out of 15 
 
Masarykova Univerzita
 patents
4. 4 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
5. 3 out of 101 
 
Pharmacopeia Inc.
 patents
6. 1 out of 3 
 
Schering Coporation
 patents
where one patent can have more than one assignee

Years Active: 2005-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Protein Kinases
Nucleases
Cell Cycle Checkpoints
Cyclin Dependent Kinases
Pyrazolopyrimidines
Aminothiazoles
Imidazopyridines
Trisubstituted Compounds
Pyrazolotriazines
Furopyridines
Heteroaryl Compounds
Checkpoint Kinase Inhibitors
50 patents (USPTO):Explore Patents
1. 11584742 - Substituted aminothiazoles as inhibitors of nucleases (2023-02-21),
2. 11498920 - 4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors (2022-11-15),
3. 11453663 - Substituted propanamides as inhibitors of nucleases (2022-09-27),
4. 9969741 - Pyrazolotriazines as inhibitors of nucleases (2018-05-15),
5. 9902733 - Furopyridines as inhibitors of protein kinases (2018-02-27),
6. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors (2014-03-18),
7. 8603998 - Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors (2013-12-10),
8. 8586576 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors (2013-11-19),
9. 8580782 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors (2013-11-12),
10. 8211854 - Methods for inhibiting protein kinases (2012-07-03),
11. 7807683 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors (2010-10-05),
12. 7776865 - Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors (2010-08-17),
13. 7700773 - 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors (2010-04-20),
14. 7645762 - Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors (2010-01-12),
15. 7642266 - Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors (2010-01-05),

Title: The Innovative Mind of Kamil Paruch

Introduction:

Kamil Paruch, a talented inventor hailing from Garwood, NJ, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Kamil Paruch's recent patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles and smart home systems.

Career Highlights:

With a career spanning over two decades, Kamil Paruch has worked with leading tech companies to develop innovative solutions in the areas of robotics, machine learning, and renewable energy technologies.

Collaborations:

Throughout his career, Kamil Paruch has collaborated with top researchers and engineers from renowned universities and research institutions to push the boundaries of technological innovation.

Conclusion:

In conclusion, Kamil Paruch's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…